(Q2)Feb 29, 2024 | (Q1)Nov 30, 2023 | (FY)Aug 31, 2023 | (Q4)Aug 31, 2023 | (Q3)May 31, 2023 | (Q2)Feb 28, 2023 | (Q1)Nov 30, 2022 | (FY)Aug 31, 2022 | (Q4)Aug 31, 2022 | (Q3)May 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | -22.00%1.54M | -18.42%1.83M | -4.44%2M | -4.44%2M | -6.57%1.83M | -18.88%1.97M | -11.44%2.25M | -23.86%2.1M | -23.86%2.1M | -33.43%1.95M |
-Cash and cash equivalents | -22.00%1.54M | -18.42%1.83M | -4.44%2M | -4.44%2M | -6.57%1.83M | -18.88%1.97M | -11.44%2.25M | -23.86%2.1M | -23.86%2.1M | -33.43%1.95M |
-Accounts receivable | 19.26%634.47K | 63.85%622.77K | -10.60%432.5K | -10.60%432.5K | -29.90%561.42K | 28.27%531.98K | -32.69%380.09K | 20.87%483.77K | 20.87%483.77K | 98.62%800.85K |
Total current assets | -12.37%2.31M | -5.55%2.59M | -4.69%2.6M | -4.69%2.6M | -12.54%2.52M | -10.94%2.64M | -15.95%2.75M | -17.64%2.73M | -17.64%2.73M | -16.68%2.88M |
Non current assets | ||||||||||
-Accumulated depreciation | 9.13%-777.44K | 16.05%-694.2K | 24.54%-617.68K | 24.54%-617.68K | -11.64%-890.15K | -20.84%-855.58K | 0.92%-826.88K | 0.08%-818.53K | 0.08%-818.53K | 2.04%-797.33K |
-Goodwill | -8.50%872.75K | 5.03%796.49K | 21.85%645.47K | 21.85%645.47K | 371.39%1.2M | 199.13%953.79K | 206.45%758.31K | 182.33%529.72K | 182.33%529.72K | 194.63%254.49K |
Regulatory assets | 20.32%698.22K | 62.92%679.1K | -4.35%491.02K | -4.35%491.02K | -25.68%612.47K | 31.02%580.3K | -33.29%416.83K | 13.23%513.37K | 13.23%513.37K | 83.11%824.13K |
Liabilities | ||||||||||
Current liabilities | ||||||||||
-Current capital lease obligation | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
-accounts payable | -1.95%101.07K | -11.81%92.66K | -5.23%110.2K | -5.23%110.2K | -6.35%108.78K | 42.48%103.07K | 3.26%105.07K | -42.64%116.29K | -42.64%116.29K | -17.61%116.16K |
-Total tax payable | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Current accrued expenses | -20.00%294.03K | -10.20%304.04K | -16.45%267.14K | -16.45%267.14K | -0.42%300.12K | -3.19%367.52K | 5.04%338.57K | 3.19%319.74K | 3.19%319.74K | -15.28%301.39K |
Current deferred liabilities | -25.95%19.3K | 62.48%27.45K | 64.95%34.71K | 64.95%34.71K | 59.69%40.76K | --26.07K | 328.32%16.89K | 147.24%21.04K | 147.24%21.04K | 40.16%25.52K |
Current liabilities | -16.56%414.4K | -7.90%424.15K | -9.85%412.06K | -9.85%412.06K | 1.48%449.65K | 9.89%496.66K | -21.45%460.53K | -38.90%457.07K | -38.90%457.07K | -44.27%443.08K |
Non current liabilities | ||||||||||
Non current accrued expenses | 123.94%531.85K | 118.56%586.44K | 105.97%642.21K | 105.97%642.21K | -42.58%206.43K | 109.93%237.5K | 2.31%268.31K | -6.58%311.79K | -6.58%311.79K | -15.45%359.49K |
Total non current liabilities | -16.56%414.4K | -7.90%424.15K | -9.85%412.06K | -9.85%412.06K | 1.48%449.65K | 9.89%496.66K | -21.45%460.53K | -38.90%457.07K | -38.90%457.07K | -45.93%443.08K |
Shareholders'equity | ||||||||||
Share capital | -3.31%9.79K | -1.96%9.92K | -0.26%10.1K | -0.26%10.1K | 0.00%10.12K | 0.00%10.12K | -1.10%10.12K | -1.40%10.12K | -1.40%10.12K | -1.68%10.12K |
-common stock | -3.31%9.79K | -1.96%9.92K | -0.26%10.1K | -0.26%10.1K | 0.00%10.12K | 0.00%10.12K | -1.10%10.12K | -1.40%10.12K | -1.40%10.12K | -1.68%10.12K |
Additional paid-in capital | -2.51%8.96M | -0.73%9.09M | 1.39%9.24M | 1.39%9.24M | 0.96%9.22M | 1.40%9.19M | 0.15%9.15M | -0.46%9.12M | -0.46%9.12M | -0.54%9.14M |
Gains losses not affecting retained earnings | 0.52%-485.11K | -4.00%-487.45K | -26.19%-474.76K | -26.19%-474.76K | -80.22%-486.2K | -63.67%-487.62K | -56.29%-468.7K | -44.07%-376.22K | -44.07%-376.22K | -101.99%-269.77K |
Total equity | -2.95%3.71M | 5.40%3.98M | 8.92%3.89M | 8.92%3.89M | 12.35%3.92M | 12.48%3.83M | -1.04%3.77M | -7.74%3.57M | -7.74%3.57M | -12.77%3.49M |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.